🇺🇸 FDA
Patent

US 12344842

Compositions and methods for treating and preventing macular degeneration

granted A61KA61K38/1793A61P

Quick answer

US patent 12344842 (Compositions and methods for treating and preventing macular degeneration) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/1793, A61P, A61P27/02